Cargando…
The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities
INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774488/ https://www.ncbi.nlm.nih.gov/pubmed/36569828 http://dx.doi.org/10.3389/fimmu.2022.1066483 |
_version_ | 1784855420424159232 |
---|---|
author | Martín-Esteban, Adrian Rodriguez, Jesus Contreras Peske, David Lopez de Castro, Jose A. Shastri, Nilabh Sadegh-Nasseri, Scheherazade |
author_facet | Martín-Esteban, Adrian Rodriguez, Jesus Contreras Peske, David Lopez de Castro, Jose A. Shastri, Nilabh Sadegh-Nasseri, Scheherazade |
author_sort | Martín-Esteban, Adrian |
collection | PubMed |
description | INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related aminopeptidases, ERAP1 and ERAP2 in humans that possess unique and complementary substrate trimming specificities. While ERAP1 efficiently trims peptides longer than 9 residues, ERAP2 preferentially trims peptides shorter than 9 residues. MATERIALS AND METHODS: Using a combination of biochemical and proteomic studies followed by biological verification. RESULTS: We demonstrate that the optimal ligands for either enzyme act as inhibitors of the other enzyme. Specifically, the presence of octamers reduced the trimming of long peptides by ERAP1, while peptides longer than nonomers inhibit ERAP2 activity. DISCUSSION: We propose a mechanism for how ERAP1 and ERAP2 synergize to modulate their respective activities and shape the MHC-I peptidome by generating optimal peptides for presentation. |
format | Online Article Text |
id | pubmed-9774488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97744882022-12-23 The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities Martín-Esteban, Adrian Rodriguez, Jesus Contreras Peske, David Lopez de Castro, Jose A. Shastri, Nilabh Sadegh-Nasseri, Scheherazade Front Immunol Immunology INTRODUCTION: Critical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding. The final trimming of MHC-I epitopes is performed by two related aminopeptidases, ERAP1 and ERAP2 in humans that possess unique and complementary substrate trimming specificities. While ERAP1 efficiently trims peptides longer than 9 residues, ERAP2 preferentially trims peptides shorter than 9 residues. MATERIALS AND METHODS: Using a combination of biochemical and proteomic studies followed by biological verification. RESULTS: We demonstrate that the optimal ligands for either enzyme act as inhibitors of the other enzyme. Specifically, the presence of octamers reduced the trimming of long peptides by ERAP1, while peptides longer than nonomers inhibit ERAP2 activity. DISCUSSION: We propose a mechanism for how ERAP1 and ERAP2 synergize to modulate their respective activities and shape the MHC-I peptidome by generating optimal peptides for presentation. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9774488/ /pubmed/36569828 http://dx.doi.org/10.3389/fimmu.2022.1066483 Text en Copyright © 2022 Martín-Esteban, Rodriguez, Peske, Lopez de Castro, Shastri and Sadegh-Nasseri https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Martín-Esteban, Adrian Rodriguez, Jesus Contreras Peske, David Lopez de Castro, Jose A. Shastri, Nilabh Sadegh-Nasseri, Scheherazade The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title | The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title_full | The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title_fullStr | The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title_full_unstemmed | The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title_short | The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities |
title_sort | er aminopeptidases, erap1 and erap2, synergize to self-modulate their respective activities |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774488/ https://www.ncbi.nlm.nih.gov/pubmed/36569828 http://dx.doi.org/10.3389/fimmu.2022.1066483 |
work_keys_str_mv | AT martinestebanadrian theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT rodriguezjesuscontreras theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT peskedavid theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT lopezdecastrojosea theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT shastrinilabh theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT sadeghnasserischeherazade theeraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT martinestebanadrian eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT rodriguezjesuscontreras eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT peskedavid eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT lopezdecastrojosea eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT shastrinilabh eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities AT sadeghnasserischeherazade eraminopeptidaseserap1anderap2synergizetoselfmodulatetheirrespectiveactivities |